Chromatin accessibility uncovers KRAS-driven FOSL2 promoting pancreatic ductal adenocarcinoma progression through up-regulation of CCL28.
Shujun ZhangPeilong LiJuan LiJie GaoQiuchen QiGuoying DongXiaoyan LiuQinlian JiaoYunshan WangChuanxin WangHanxiang ZhanShuo XuChuanxin WangPublished in: British journal of cancer (2023)
Our study uncovered that KRAS-driven FOSL2 promoted PDAC progression by transcriptionally activating CCL28, revealing an immunosuppressive role for FOSL2 in PDAC.